Quantitative and temporal features of maternal-fetal transport of IgG in the chicken have been determined by means of a sensitive and specific radioimmunoassay. The first step in this two-step process is the transport of maternal IgG from the hen plasma across the oolemma into the maturing oocyte in the ovarian follicle. Oocytes sequester IgG throughout most of their maturation from 10 mg pre-vitellogenic oocytes to fully mature 20 g oocytes ready to be shed into the oviduct. IgG uptake is exactly proportional to mass accumulation at every point. Thus, the concentration of IgG in the yolk is invariant throughout maturation of the oocyte (approximately 8 mg/ml) and the rate of uptake in this single specialized cell can be as great as 45 mg/day during its last 3 days of growth before ovulation. The second step, uptake of yolk IgG across the yolk sac and into the fetal circulation, is detectable at the earliest time points tested (Day 7), but accumulation into the embryonic plasma occurs at a relatively low rate (less than 100 micrograms/day) until a dramatic increase in uptake (greater than 600 micrograms/day) occurs in the last 3 days before hatching. The hatchling has 1-2 mg/ml of maternal IgG in its plasma. Increase in IgG uptake lags significantly (approximately 4 days) behind increase in mass by the developing embryo, suggesting that IgG uptake occurs predominantly in the last few days before hatching. This ensures that the hatching is endowed with those maternal IgGs which will be its planopy when it enters the hostile world.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1453552PMC

Publication Analysis

Top Keywords

igg uptake
12
igg
10
maternal igg
8
igg yolk
8
occurs days
8
days hatching
8
uptake
6
quantitation maternal-fetal
4
maternal-fetal igg
4
igg transport
4

Similar Publications

Active biomonitoring of mercury (Hg) using non-indigenous moss bags was performed for the first time within and around the former Hg mining area of Abbadia San Salvatore (Mt. Amiata, central Italy). The purpose was to discern the Hg spatial distribution, identify the most polluted areas, and evaluate the impacts of dry and wet deposition on mosses.

View Article and Find Full Text PDF

Background/objectives: Since the World Health Organization declared COVID-19 a pandemic in March 2020, the virus has caused multiple waves of infection globally. Arizona State University (ASU), the largest four-year university in the United States, offers a uniquely diverse setting for assessing immunity within a large community. This study aimed to test our hypothesis that an increased number of exposures to SARS-CoV-2 RBD through vaccination/boosters/infection will increase SARS-CoV-2 antibody seroprevalence by increasing the longevity of anti-RBD and anti-RBD-neutralizing antibodies.

View Article and Find Full Text PDF

Cyclic peptides are often used as scaffolds for the multivalent presentation of drug molecules due to their structural stability and constrained conformation. We identified a cyclic deca-peptide incorporating lipoamino acids for delivering T helper and B cell epitopes against group A Streptococcus (GAS), eliciting robust humoral immune responses. In this study, we assessed the function-immunogenicity relationship of the multi-component vaccine candidate (referred to as VC-13) to elucidate a mechanism of action.

View Article and Find Full Text PDF

A VZV-gE subunit vaccine decorated with mPLA elicits protective cellular immmune responses against varicella-zoster virus.

Int Immunopharmacol

January 2025

Department of Pharmaceutics, School of Pharmacy, Ningxia Medical University, Yinchuan, Ningxia, China. Electronic address:

Herpes zoster is an acute infectious skin disease caused by the reactivation of latent varicella-zoster virus, vaccination, such as subunit vaccine with good safety, can effectively prevent shingles through increasing immunity of the body. However, protein antigens are prone to degradation and inactivation, which alone is generally not sufficient to induce potent immune effect. In this study, the liposomal vaccine platform modified with mPLA (TLR4 agonist) was developed to improve the immunogenicity of glycoprotein E (VZV-gE) derived from herpes zoster virus.

View Article and Find Full Text PDF

BackgroundThe first Corona Monitoring Nationwide (RKI-SOEP) study (October 2020-February 2021) found a low pre-vaccine SARS-CoV-2 antibody seroprevalence (2.1%) in the German adult population (≥ 18 years).AimThe objective of this second RKI-SOEP (RKI-SOEP-2) study in November 2021-March 2022 was to estimate the prevalence of SARS-CoV-2-specific anti-spike and/or anti-nucleocapsid (anti-N) IgG antibodies (combined seroprevalence), past infection based on infection-induced seroprevalence (anti-N), and basic immunisation (at least two antigen contacts through vaccination or infection) in individuals aged ≥ 14 years.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!